Related by context. All words. (Click for frequent words.) 78 KSP inhibitor 76 Ispinesib SB # 75 kinesin spindle protein KSP 75 Kinesin Spindle Protein KSP 68 1 Bucureşti cod 68 CYP#A# CYP#D# 68 Popa Tatu sector 68 = gat. getTracker UA 68 mitotic kinesin 67 brivanib 67 try var pageTracker 67 XL# anticancer compounds 66 AAG geldanamycin analog 66 IAP inhibitor 66 Ref. # 66 II antagonist CORT 66 dasatinib Sprycel ® 66 novel histone deacetylase 66 Zhenhua Port Machinery SHB 65 novel VDA molecule 65 MET VEGFR2 65 non nucleoside inhibitor 65 adenosine A2A 65 mertansine 65 certain protein tyrosine 65 CD4 monoclonal antibody 64 NEWS NDTV HINDU 64 virus HCV protease inhibitor 64 deb Size/MD5 # Size/MD5 [001] 64 accumulate preferentially 64 AKT inhibitor 64 pan histone deacetylase 64 oral nucleoside analogue 64 China ICBC SHA 64 small molecule Hedgehog 64 non nucleoside HCV 64 selective kinase inhibitor 64 SNP Sinopec SHA 64 orally administered inhibitor 64 GSK '# 64 histone deacetylase HDAC inhibitor 64 small molecule glucokinase 64 oral prodrug 64 PegIFN 64 cyclin dependent kinase CDK 64 reversible inhibitor 64 China Vanke SZB 64 multi kinase inhibitor 64 Janus kinase 63 safety tolerability pharmacodynamics 63 alpha folate receptor 63 NDTV HINDU NIGHT VISION 63 Elisha Dacey Story 63 IKK epsilon 63 targeted antifolate 63 histone deacetylase inhibitor 63 5 HT6 receptor 63 China Vanke SZA 63 diabetic neuropathy DN 63 TKB# 63 OMP #R# 63 investigational humanized monoclonal antibody 63 Daniel Hayduk Story 63 Saurashtra Crushing Quality 63 cortisol synthesis 63 oral Janus kinase 63 humanized therapeutic 63 selective inhibitor 63 pan HDAC inhibitor 63 5 HT2A serotonin 63 #NNNN 63 inflammatory PDE 63 VEGFR2 inhibitor 63 THE LATE NIGHT 63 novel tubulin binding 63 cyclin dependent kinase inhibitor 63 BACON SANDWICH PICKLES SANDWICH 62 DX JUN# 62 ADP receptor antagonist 62 histone deacetylase HDAC 62 selective serotonin 2C receptor 62 CYT# potent vascular disrupting 62 Kinase Inhibitor 62 PNP inhibitor 62 NS5b 62 HCV RNA polymerase 62 Aflibercept 62 aurora kinase inhibitor 62 cathepsin K inhibitor 62 FIRST CHINA PROPERTY 62 5 HT4 62 NSE SUNPHARMA BSE 62 mso font signature 62 oral proteasome inhibitor 62 e mail babewaxpak@charter.net 62 e mail ellengoodman@globe.com 62 apoptosis proteins 62 potent antiproliferative 62 proteasome inhibitor 62 peripherally restricted 62 targeting CD# 62 folate analogue metabolic 62 Janus Kinase 62 2 inhibitor CYT# 62 selective antagonist 62 vesicular monoamine transporter 62 NS5B polymerase 62 directed radiotherapeutic antibody 62 dimebon latrepirdine 62 targeted radiotherapeutic 62 MT# MEDI 62 PEGylated Fab fragment 62 developing Zerenex ferric 62 pharmacodynamic profile 62 V8 AUTO W 62 5 HT2A inverse 62 novel emulsion formulation 61 Rigel R# 61 nhunter@jacksonsun.com 61 selective modulator 61 HSP# inhibitor 61 Picture EMILY LANE 61 peptidic compound 61 liposome encapsulated 61 Telik logo TELINTRA 61 poly ADP ribose polymerase 61 oral JAK1 61 T#N R#W Caspiana 61 selective inhibition 61 AUTO 5SPD 61 liposomal formulation 61 Rachael Kimola Story 61 ENMD # 61 Mg Uk 61 adecatumumab MT# 61 Talabostat 61 inhibitor COX 61 Aurora Kinase 61 IMPDH inhibitor 61 DNA methyltransferase inhibitors 61 cetuximab Erbitux R 61 receptor tyrosine kinase inhibitor 61 aurora kinase 61 DGAT 61 nucleoside analog 61 candidate deforolimus 61 JAK2 inhibitor 61 pralatrexate injection folate analogue 61 sodium glucose cotransporter 61 TLR7 agonist 61 agonistic human 61 Atripla combines 61 Meets Primary Endpoint 61 MTP inhibitor 61 B# HP Compaq 61 Fc fusion protein 61 Anidulafungin 61 selective A2A adenosine receptor 61 Annamycin 61 Aplidin R 61 Degarelix 61 orally dosed 60 taxane derivative 60 inverse agonist 60 defensin mimetic antibiotic 60 imatinib Gleevec ® 60 Picture SARAH MATRAY 60 Romidepsin 60 2 methoxyestradiol 60 novel orally administered 60 PDGFR B 60 vinorelbine tartrate 60 Preclinical studies suggest 60 WWW.OTS.AT * OTS# #-#-#/# 60 Epothilones 60 small molecule tyrosine 60 muscarinic 60 alefacept 60 HCV polymerase 60 mda 7 60 oral kinase inhibitor 60 IMiDs ® 60 effector function 60 neuroregenerative 60 PARP inhibitor 60 HDAC Inhibitor 60 thrombin receptor 60 # i#.deb Size/MD5 60 metaglidasen 60 vascular disrupting agents 60 fusion enhancers 60 thymidylate synthase 60 TO AVOID PREGNANCY WHILE 60 alpha#beta# integrin 60 kidney urologic 60 RON Notch 60 cisplatin resistant 60 IgG1 monoclonal antibody 60 JAK2 Inhibitor 60 Hsp# Inhibitor 60 EXPEDITION 5DR UTILITY #.#L 60 RAS MAPK pathway 60 HCV protease 60 JAK inhibitor 60 TRIOLEX HE# APOPTONE HE# 60 EOquin TM phase 60 Initiates Phase II 60 EnVivo Pharmaceuticals Inc. 60 # amd#.deb Size/MD5 60 Epidermal Growth Factor Receptor 60 receptor agonists 60 tramiprosate Alzhemed TM 60 Bortezomib 60 antitumoral 60 anti miRs antisense oligonucleotide 60 CREW CAB #.#L V6 60 visit http:/www.earnparttimejobs.com/index.php?idSheffield Hallam MP 60 arc.deb Size/MD5 60 CDK cyclin dependent 60 reversible inhibitors 59 Initiates Phase 59 tumor vascular disrupting 59 J Natl Cancer Inst 59 Kahalalide F 59 OTE# #-#-#/# 59 Archexin 59 Sudhir Agrawal D.Phil 59 anti angiogenic agent 59 erlotinib Tarceva ® 59 powerpc di #.#.#.# #.# powerpc.udeb Size/MD5 59 oral Factor Xa 59 interleukin IL -# 59 XOMA 3AB biodefense 59 powerpc di #.#.# #.# powerpc.udeb Size/MD5 59 Don Klepp Story 59 mitogen activated ERK kinase 59 #.deb Size/MD5 [002] 59 anti secretory 59 triggers apoptosis programmed 59 agonists antagonists 59 powerpc.deb Size/MD5 59 May #NNNN 59 THR beta agonist 59 MT#/MEDI-# 59 DP VPA 59 topical gel formulation 59 anti amnesic 59 budesonide foam 59 V8 SILVER AUTO 59 PrevOnco 59 MKC# MT 59 HGS ETR2 59 CROWN VICTORIA 4DR #.#L 59 Lenocta TM sodium stibogluconate 59 metastatic malignant 59 code SPD# 59 DEB# 59 novel peptide 59 targets HGF FGFR 59 neuronal nicotinic receptor NNR 59 :/ click Size/MD5 checksum 59 Factor Receptor 59 PI3K/Akt pathway inhibitor 59 rgauthier@coxohio.com 59 dmorris@jacksonsun.com 59 EGFR HER2 59 Pemetrexed 59 Trastuzumab DM1 59 Tesmilifene 59 #-#-# Replay Passcode 59 6.deb Size/MD5 59 plasma pharmacokinetics 59 protein tyrosine phosphatase 1B 59 anionic backbone 59 highly selective endothelin 59 Bruton tyrosine kinase Btk 59 Factor VIIa 59 psoriasis rheumatoid arthritis 59 sunitinib Sutent ® 59 Recap TOR 59 Multimeric 59 Receptor Antagonist 59 V8 AUTO 4SPD 59 Maxy G# 59 NU# direct 59 Bloomberg SUNP IN 59 selective inverse agonist 59 candidate REP# 59 SGLT 2 59 FLT3 59 Tumor necrosis factor 59 INDIA Fax +#-# 59 investigational protease inhibitor 59 di #.#.#.# #.# i#.udeb Size/MD5 59 subcutaneously administered 59 5 fluorouracil leucovorin 58 cholesteryl ester transfer 58 MEK inhibitor 58 Angiotensin Converting Enzyme 58 humanized monoclonal antibody 58 HCV replicon 58 J Clin Psychiatry 58 RTP #i 58 Initiates Enrollment 58 cytokine refractory 58 Apoptone HE# 58 Enzastaurin 58 anti CD3 58 Reproduced Record RR 58 Darinaparsin Zinapar TM 58 AUSSENDERS * OTE# #-#-#/# 58 agonist compounds 58 humanized anti 58 triciribine phosphate monohydrate 58 secretory phospholipase A2 58 potent cytotoxic 58 small molecule thrombopoietin 58 JAK#/JAK# 58 Intravenous CP 58 Vidaza ® 58 peptibody 58 thalidomide Thalomid 58 HuLuc# 58 IGF1R 58 Initiate Phase 58 EXPLORER SPORT TRAC 4DR 58 GVAX ® 58 downstream effectors 58 ALS #-# 58 AEG# 58 PEG irinotecan 58 EZN 58 tyrosine kinase receptor 58 Completes Patient Enrollment 58 cytotoxic T lymphocyte 58 selectively binds 58 JAK1 58 dipeptidyl peptidase IV 58 c.deb Size/MD5 58 Pazopanib 58 Sphingomab 58 #HT# 58 commercialize CorMedix drug 58 drug conjugate 58 novel therapeutic antibodies 58 Alfacell proprietary ribonuclease 58 anti CD3 monoclonal 58 attach auristatin 58 signal transduction inhibitor 58 LIANA PTY 58 Darapladib 58 PRN FDA Approves 58 delta opioid receptor 58 immunomodulatory 58 Peroxisome Proliferator Activated Receptor 58 website http:/www.earnparttimejobs.com/index.php?admin node 58 Panzem R 58 partial agonist 58 MACQUARIE AUSTRALIA PTY LIMITED 58 MSCRAMM ® 58 treatment naive genotype 58 Panzem NCD 58 oral immunomodulatory 58 SCH # 58 PSN# [002] 58 Dasatinib 58 IMiDs R 58 USA Serial Number 58 nucleotide analog 58 M# rationally 58 receptor agonist 58 OncoVex 58 AIRPORT MOTORWAY CUSTODIANS PTY 58 abacavir lamivudine 58 cyclooxygenase COX 58 selective immunoproteasome inhibitor 58 Drug Candidate 58 Gleevec resistant 58 PDE4 inhibitor 58 TLR9 agonist 58 non thiazolidinedione TZD 58 LymphoStat B belimumab 58 MKC# MKC# PP 58 WWW.OTS.AT * OTE# #-#-#/# 58 R bisoprolol Euthyrox 58 selectively inhibited 58 CCX# 58 NKT Holding CSE DK 58 sphingosine 1 58 panitumumab Vectibix 58 rpc.deb Size/MD5 58 CG# [003] 58 VEGF receptor 58 Achieves Primary Endpoint 58 echinocandin 58 HCD# [002] 58 vascular disrupting agent 58 Babe Waxpak Box 58 E#F# 58 novel L DOS# 58 evaluating satraplatin 58 BRAF kinase 58 methyl D aspartate 57 Xanafide 57 Submits NDA 57 Adenosine A2A 57 IMC #B 57 CDK4 57 HQK 57 humanized monoclonal antibodies 57 antibody MT# 57 Presents Preclinical Data 57 mTOR inhibitors 57 MGd 57 semi synthetic lipoglycopeptide 57 radiation sensitizer 57 HDACi 57 FIRST USE 57 YONDELIS 57 Replay Passcode 57 therapeutic monoclonal antibody 57 Ecallantide 57 bleomycin 57 NEUGENE antisense 57 MCSP respectively 57 i#.deb Size/MD5 57 GW# [003] 57 flavopiridol 57 elotuzumab 57 Commences Phase 57 Merck OSI Pharmaceuticals 57 Decitabine 57 plasmid encoding 57 pathophysiological effects 57 Glucagon Like Peptide 57 4.deb Size/MD5 57 Abstract Number 57 ritonavir boosted 57 mso font signature -# 57 Darinaparsin 57 Protease Inhibitor 57 receptor inhibitor 57 PDE# 57 ONTARIO LTD CANADA 57 thiazolides 57 anti botulism antibody 57 polycythemia vera PV 57 beta 1a 57 Randomized Phase 57 Peginterferon 57 4SPD 57 TransVax tm 57 PEGylated 57 humanized interleukin 6 57 Omacetaxine 57 Immunotherapeutic 57 syngeneic 57 Pruvel TM 57 alpha#beta# 57 selective agonist 57 candidates Azedra TM 57 nilotinib Tasigna 57 inhibit angiogenesis 57 PDE4 57 nicotinic alpha 7 57 CD# monoclonal antibody 57 TOWN CAR 4DR 57 Xcytrin R 57 irreversible inhibitor 57 dopamine D2 57 Peginterferon Alfa 2a 57 induces apoptosis 57 IFN α 57 oral anti arrhythmic 57 then enter TIP# 57 receptor CXCR4 57 5 lipoxygenase 57 intranasal formulation 57 TLR antagonist 57 delta gamma agonist 57 PF # [002] 57 hepatoma 57 receptor modulators 57 CYC# 57 anti CTLA 57 Aleratec Part 57 Ex Saurashtra #/#.# 57 TransVax ™ 57 sulfonylhydrazine class 57 es #.#.# 57 Cannabinor 57 thyroid hormone receptor 57 OMP #M# 57 Trabectedin 57 Active Ulcerative Colitis 57 ceftazidime 57 volociximab 57 Orally administered 57 small molecule inhibitor 57 Begins Dosing 57 receptor inhibiting monoclonal 57 topoisomerase II 57 5 FU leucovorin 57 Zoraxel TM 57 selective phosphodiesterase 57 RhuDex ® 57 CYT# QbG# 57 R sorafenib tablets 57 Systemic Delivery 57 cytotoxin 57 inhibit metastasis 57 -#-# 3 57 Idera Pharmaceuticals develops 57 DNA intercalator 57 compound PMX # 57 HepDirect prodrug 57 sorafenib Nexavar 57 FOR LICENCE ENQUIRIES 57 soluble tumor necrosis 57 mso fareast language 57 ,#,# [002] 57 replicon 57 PDX pralatrexate 57 b Size/MD5 57 Receives Orphan Drug Designation 57 5alpha reductase 57 myelofibrosis polycythemia vera 57 Successfully Completes Phase 57 Recap BAL 57 HER1 56 gemcitabine cisplatin 56 NPC 1C 56 antidiabetic 56 Antigen Specific 56 5 HT6 56 iobenguane 56 Topoisomerase II 56 eb Size/MD5 # 56 Aliskiren 56 Initiates Phase III 56 LPA1 56 cells uL 56 Piperacillin 56 IG HCR ;) CO 56 receptor partial agonist 56 vidofludimus 56 Tumor Necrosis Factor 56 C5aR 56 PEG SN# 56 Phase 2b Clinical Trial 56 antitumor effect 56 oral rivaroxaban 56 chemokine receptor 56 Daclizumab 56 # eb Size/MD5 56 Initiates Clinical 56 Presents Preclinical 56 antisense inhibitor 56 parc.deb Size/MD5 56 MediGene focuses 56 TRO# 56 Vytorin combines 56 tumor antigen 56 CRTH2 56 Posiphen 56 antiangiogenic 56 Kosan proprietary 56 DFMO 56 antiangiogenic agent 56 Oral NKTR 56 KB# [002] 56 potently inhibit 56 COX2 56 Med Assoc 56 NK1 56 Albuferon albinterferon alfa 2b 56 platform HDL Mimetic 56 protein kinase inhibitor 56 peripherally acting 56 werpc.deb Size/MD5 56 Ziprasidone 56 TLR9 agonists 56 Ixabepilone 56 potently inhibited 56 deb Size/MD5 56 Vidaza R 56 Muraglitazar 56 b CUSIP Number 56 chimeric monoclonal antibody 56 erpc.deb Size/MD5 56 commercializing oxidized glutathione 56 regorafenib 56 infectious diseases autoimmune diseases 56 TRAIL receptor 56 Secretase 56 non porcine pancreatic 56 Long acting beta2 56 prucalopride 56 antimitotic 56 selectively induce apoptosis 56 receptor blocker 56 Eg5 56 oral antiviral 56 hypoxia selective 56 Anticancer Compound 56 5 HT2A receptor 56 infectious diseases autoimmune 56 Delta opioid receptor 56 R roscovitine 56 Tumour Vascular Disrupting Agent 56 highly selective inhibitor 56 Groundnut seed 56 Phase 2a Clinical Trial 56 Recombinant Human 56 CCR2 56 demonstrated antitumor activity 56 # eb Size/MD5 checksum 56 proteasome inhibitors 56 sargramostim 56 mso bidi language 56 monoclonal antibody MAb 56 Phase 1b Clinical Trial 56 receptor PPAR 56 microtubule inhibitor 56 pc.deb Size/MD5 56 Receptor Antagonists 56 Vascular Endothelial Growth 56 generic di #.#.#.# #.# i#.udeb Size/MD5 56 Pegylated 56 Adenoviral 56 includes TOLAMBA TM 56 selectively inhibit 56 CB2 selective receptor agonist 56 reformulates existing FDA 56 Flt3 56 SinuNase ™ 56 anti atherothrombotic 56 outlicensed 56 itraconazole Sporanox 56 γ secretase 56 overactive bladder AA# 56 Swedenburg v. Kelly 56 IMC A# 56 topical antifungal product 56 eid = 56 #beta HSD1 56 somatostatin analogue 56 HCV protease inhibitor 56 PG HBO2 56 var pageTracker = gat. getTracker 56 Pharmacokinetic Study 56 meropenem 56 Crimestoppers anonymously tel 56 Int Clin Psychopharmacol 56 cytostatic 56 LX# LX# 56 administered subcutaneously 56 Aganocide ® 56 5 HT2A 56 BUPHENYL R sodium phenylbutyrate 56 Recap TEX 56 cleavable linker 56 mGluR2 NAM 56 bevacizumab Avastin ® 56 MAb 56 gastro intestinal inflammation 56 Filed #-#-# 56 Fulvestrant 56 Annexin V 56 HCV polymerase inhibitors 56 Protein Kinase 56 pharmacologically active isomer 56 biologic DMARD 56 isoform selective 56 JAK inhibitors 56 Luteinizing Hormone Releasing Hormone 56 callers passcode 56 siRNA therapeutic 56 luteinizing hormone releasing 56 PrevOnco ™ 56 CYT# vascular disrupting 56 HBeAg negative 56 epigenetic therapies 56 regulated kinase 56 selectively inhibiting 56 anticancer therapeutics 56 Y2 receptor 56 generation nucleoside analog 56 Interferon alfa 56 immunomodulator 56 potent suppressor 56 cyclin dependent kinase 56 MDR1 55 vemurafenib 55 erlotinib Tarceva 55 selectin antagonist 55 Pathway Inhibitor 55 Protein Kinase C 55 potent inhibition 55 CCR1 55 mGluR5 antagonists 55 Initiated Phase 55 interferon lambda 55 glutamyl 55 Granulocyte Colony Stimulating Factor 55 Liposomal 55 TRAIL Receptor 55 oral inducer 55 pharmacodynamic properties 55 opioid receptor antagonist 55 adrenoceptor 55 immune globulin intravenous 55 Pertuzumab 55 Cathepsin S 55 pharmacodynamic effects 55 b Size/MD5 # [002] 55 Voreloxin 55 lamivudine 3TC 55 Redding CA #-# 55 inhibit oxidative stress 55 DOI #.#/S#-# 55 Frankfurt WKN # [001] 55 PDGF alpha receptor 55 STEDESA 55 text keyword SSM 55 Vaxfectin 55 BOSTON AUSTRALIA PTY 55 CD# CEA 55 A3 adenosine receptor 55 IMiD 55 DES AUSSENDERS WWW.OTS.AT * 55 deb Size/MD5 # Size/MD5 [002] 55 Angiocept 55 Therapeutic Competitors Companies 55 tumorigenicity 55 histone deacetylation 55 ord = 55 selective adenosine 55 deb Size/MD5 # [002] 55 telomerase therapeutic 55 Onconase 55 neuropathic pain spasticity 55 alpha 2A adrenergic 55 SAR# [002] 55 Trubion proprietary 55 cytotoxic antibody 55 ZFP TF 55 Picture GLEN CAMPBELL 55 immunomodulatory effects 55 generation purine nucleoside 55 PANVAC VF 55 Reports Preclinical Data 55 potent inducer 55 chemokine SDF 1 55 2A receptor agonist 55 M2 subunit 55 metastatic colorectal 55 Camptosar ® 55 dependent cellular cytotoxicity 55 mitogenic 55 Novel Oral 55 ghrelin agonist 55 HIV treatments Reyataz 55 RESF NO 55 Submits IND 55 enhance ApoA 55 gonadotropin releasing hormone GnRH 55 paclitaxel Taxol ® 55 p# MAPK 55 5 Fluorouracil 55 Initiates Clinical Trial 55 symbol TVC WKN 55 midstage clinical 55 Maribavir 55 oncolytic virus therapies 55 alkylating 55 T#I mutant 55 adriamycin 55 inhaled formulation 55 cisplatin gemcitabine 55 # Aetna 55 xenograft models 55 cytokines IL 55 Tipranavir 55 vinblastine 55 HER pathway 55 immune modulatory 55 CYP #D# 55 immune stimulatory 55 #.# subd [003] 55 immunostimulatory 55 Files IND 55 OXIGON TM 55 Evoltra ® 55 tumor xenograft models 55 Irinotecan 55 PI3K inhibitor 55 Coupe SLE V6 Mileage 55 glycogen synthase kinase 55 immune modulator 55 novel orally bioavailable 55 retinoic acid receptor 55 Metres NTKM went 55 #ME# 55 texting CTBREAKING 55 SPRYCEL ® 55 small molecule modulators 55 VEGFR 55 AUTO 4SPD 55 peroxidase 55 introduced NEUGENE 55 using VIAdel TM 55 MODEL NUMBER 55 sphingosine kinase 55 synthetic anti infective 55 XP# XP# 55 Biogen Genentech 55 Quay Bristol BS1 55 negative allosteric modulator 55 Pixantrone BBR 55 synthetic peptide 55 RNA antagonists 55 protein kinase inhibitors 55 oxazolidinone 55 kinase PI3K 55 Toyota Camry Solara 2d 55 ALTROPANE R 55 activin receptor type 55 intravesical instillation 55 related apoptosis inducing 55 interleukin IL 55 Inc. Nasdaq MITI 55 solithromycin 55 Antisense 55 Industry Definition NAICS 55 ribavirin RBV 55 ribonucleotide reductase clinically validated 55 TLR8 55 Antibody Drug Conjugate 55 immunomodulatory therapy 55 CDK5 55 IAP inhibitors 55 #I TM# 55 thrombopoietin TPO 55 delta isoform 55 Prodrug 55 polysaccharide polymer 55 please visit http:/www.vandapharma.com 55 inhibiting viral replication 55 thymalfasin 55 VEGFR2 55 deforolimus 55 multikinase inhibitor 55 TLR agonists 55 #-#-# Int'l passcode 55 benzothiazole 55 herpetic keratitis 55 telomerase reverse transcriptase 55 hyaluronidase enzyme 55 TELINTRA R 55 TLR7 55 pegylated interferons 55 Haynesville RA 55 Rindopepimut 55 mitogen activated protein kinase 54 Small Modular SMIP 54 HIV reverse transcriptase 54 nucleoside analogues 54 Sphingomab TM 54 GRAND MARQUIS 4DR #.#L 54 AGS PSCA 54 endogenous ligands 54 Submits Biologics License Application 54 MMAE 54 sapacitabine CYC# 54 peptidomimetic 54 monoclonal antibody mAb 54 motexafin gadolinium Injection 54 pomalidomide 54 Recap HOU 54 Upregulation 54 5 HT2C 54 CU NP 54 Dose Escalation 54 targeted diseased tissues 54 ADAMTS# 54 MKC# 54 protein tyrosine phosphatases 54 Tubulin 54 TBC M4 54 peptide CGRP 54 mediated inhibition 54 ERK1 2 54 Antigenics QS 54 Fedora alert FEDORA 54 checksum # Size/MD5 checksum [001] 54 Saxagliptin 54 Tyrosine Kinase Inhibitor 54 targets Galectin receptors 54 sodium glucose transporter 54 factor Xa 54 somatostatin 54 sparc.deb Size/MD5 54 epothilones 54 compound AEZS 54 See ARS § 54 gastrin analogue TT 54 fibrotic disorders 54 tiapamil 54 China Chalco SHA 54 Nom du Keyboard 54 FOLFOX6 54 jsmith@equicomgroup.com 54 basiliximab 54 Franklin MI #-# 54 OXi# 54 liposomal doxorubicin 54 Monopril 54 treating neuropathic pain 54 checksum # Size/MD5 checksum [002] 54 Leuprolide 54 Ceflatonin R 54 histone deacetylase 54 #.#L V8 AUTO 4SPD 54 radiolabeled 54 SGLT2 inhibitor 54 XOMA 3AB 54 d#.deb Size/MD5 54 hepatotoxic 54 cyclophosphamide methotrexate 54 conjugated estrogens 54 initiated Phase Ib 54 virus HBV 54 alpha TNFa 54 ALN VSP Phase 54 cMet 54 3TC lamivudine 54 platelet inhibitor 54 Pharma Merck Serono 54 B lymphocyte stimulator 54 microsomal triglyceride transfer 54 Klong Toey Bangkok 54 Thiarabine 54 LPA1 receptor 54 pramipexole dihydrochloride 54 selective orally bioavailable 54 Gammagard Liquid 54 Deadlinepix 54 Locked Nucleic Acid 54 TIMP 1 54 AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES 54 ART# 54 gonadotrophin releasing hormone GnRH 54 selective estrogen receptor modulator 54 LSE Trading Symbol 54 neuropathic pain metabolic diseases 54 Hormone Refractory Prostate Cancer 54 auristatin 54 alpha 2a 54 cyclin dependent kinases 54 ASONEP ™ 54 chemotherapeutic drug 54 deoxy 54 MANAGEMENT LIMITED HONG KONG 54 Squalamine 54 inhalation aerosol 54 text YELE 54 cilengitide 54 4DR CREW CAB #.#L 54 Solazed TM 54 #:# abstract 54 Drivewatch Hotline 54 Pivotal Phase 54 Quinamed R 54 Inotek Pharmaceuticals Corporation 54 SynCon 54 NO.1 PTY LIMITED AUSTRALIA 54 neurotrophic 54 HCl Injection 54 neurokinin 1 54 THE STORMS HAVE 54 gamma amino butyric 54 Lubiprostone 54 oral candidiasis 54 orally inhaled migraine 54 Chemokine Receptor 54 IMA# 54 NYSE SKM KSE 54 b Size/MD5 # [001] 54 Initiates Phase 2b 54 topoisomerase II inhibitor 54 Replay Pin Number 54 cell adhesion molecule 54 clomipramine 54 TLR3 54 # SELECT 54 small molecule inhibitors 54 methionine aminopeptidase 54 potent anticancer